Journal ArticlePLoS One · 2025
INTRODUCTION: HIV poses a significant global health concern, affecting adolescents among other populations. This is attributed to various vulnerabilities including biological factors, gender inequalities and limited access to comprehensive sexual and repro ...
Full textLink to itemCite
Journal ArticleJ Clin Virol · December 2024
BACKGROUND: The WHO HIV testing algorithm for high prevalence populations recommends the use of three different serologic assays, though this approach may lead to diagnostic misclassification. The study objective was to compare dried blood spot (DBS)-based ...
Full textLink to itemCite
Journal ArticleBMC Pregnancy Childbirth · April 24, 2024
BACKGROUND: HIV partner counselling and testing in antenatal care (ANC) is a crucial strategy to raise the number of males who know their HIV status. However, in many settings like Tanzania, male involvement in antenatal care remains low, and there is a de ...
Full textOpen AccessLink to itemCite
Journal ArticleAdvances in Medical Education and Practice · January 1, 2024
Background: Effective implementation of new curricula requires faculty to be knowledgeable about curriculum goals and have the appropriate pedagogical skills to implement the curriculum, even more so if the new curriculum is being deployed at multiple inst ...
Full textCite
Journal ArticlePLoS One · 2024
BACKGROUND: Mothers attending prevention of mother-to-child transmission (PMTCT) of HIV clinics seem to lack knowledge on many aspects of PMTCT, among which is breastfeeding. Breastfeeding recommendations in PMTCT have changed several times over the years ...
Full textLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr · December 15, 2023
BACKGROUND: Compared with the general cancer population, people living with HIV (PLWH) and cancer are less likely to receive treatment and have significantly elevated cancer-specific mortality for many common cancer types. Physician recommendations drive t ...
Full textLink to itemCite
Journal ArticleInt J Gynaecol Obstet · July 2023
OBJECTIVE: The current study assessed pregnant individuals' intention to accept routine and COVID-19 vaccines for their baby after birth, and to identify key demographic (e.g., age) and nondemographic characteristics (e.g., prior birth) associated with vac ...
Full textLink to itemCite
Journal ArticleMed Teach · July 2023
In many low- and middle-income countries, there seems to be a mismatch between graduate skills and healthcare industry requirements due to variability in curricula. With the current increased global demand for competent health profession graduates, harmoni ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · May 1, 2023
PURPOSE: Cancer is now the leading cause of non-AIDS death in the US population with HIV. People living with HIV (PLWH) are known to have lower cancer treatment rates and worse cancer outcomes. Disparate cancer treatment is driven by health system, patient ...
Full textLink to itemCite
Journal ArticleBMC Endocr Disord · April 21, 2023
BACKGROUND: HIV and antiretroviral drugs, particularly protease inhibitors and nucleoside reverse transcriptase inhibitors, may increase the risk of Metabolic Syndrome (MetS) among people living with HIV (PLHIV). However, following the introduction of bett ...
Full textLink to itemCite
Journal ArticleInfect Drug Resist · 2023
BACKGROUND: Introduction and expansion of antiretroviral therapy (ART) have turned the tide of HIV pandemic, thus helping people living with HIV (PLHIV) achieve viral suppression. This success may need to be complemented by intensified adherence counseling ...
Full textLink to itemCite
Journal ArticleFront Urol · 2023
BACKGROUND: The extent of the burden of erectile dysfunction and its associated factors remains unclear. The aim of this study was to investigate the factors associated with ED and its prevalence among MLHIV in northern Tanzania. METHODS: A hospital-based, ...
Full textLink to itemCite
Journal ArticleBMJ Open · December 19, 2022
INTRODUCTION: Most of the global non-communicable disease (NCD)-related death burden is borne by low and middle-income countries (LMICs). In LMICs like Pakistan, however, a major gap in responding to NCDs is a lack of high-quality research leading to polic ...
Full textLink to itemCite
Journal ArticleCurr Hypertens Rep · August 2022
PURPOSE OF REVIEW: The objective of this study was to describe the increasing incidence and risk of cardiovascular disease among persons living with HIV (PLWH) in Sub-Saharan Africa. We also used data to compare hypertension (a common NCD among PLWH) outco ...
Full textLink to itemCite
Journal ArticleInt Health · July 1, 2022
BACKGROUND: Little is known about healthcare-seeking behaviour and barriers to care for cardiovascular disease (CVD) in sub-Saharan Africa. METHODS: Emergency department patients in Tanzania with acute CVD were prospectively enrolled. Questionnaires were a ...
Full textOpen AccessLink to itemCite
Journal ArticleAm J Health Behav · April 20, 2022
Objectives: In this study, we explored determinants of "researcher-observed" patient-initiated antiretroviral therapy (ART) repackaging practices among people living with HIV (PLHIV) in Northern Tanzania. Methods: We used a quasi-experimental design to des ...
Full textLink to itemCite
Journal ArticlePLoS One · 2022
INTRODUCTION: Health insurance coverage is critical for persons living with chronic conditions such as heart failure. Lack of health insurance may affect the ability to access regular healthcare appointments, pay for medication refills which can result in ...
Full textLink to itemCite
Journal ArticlePatient Prefer Adherence · 2022
PURPOSE: We sought to assess how HIV-positive mothers enrolled in the PMTCT program adhere to breastfeeding recommendations concerning early initiation of breastfeeding (EIBF), ie, within one hour of birth, pre-lacteal feeds, exclusive breastfeeding until ...
Full textLink to itemCite
Journal ArticleAdv Med Educ Pract · 2022
BACKGROUND: Mentorship is pivotal for sustainability of a successful research culture at higher learning institutions. Various models have been proposed for provision of research mentorship in health sciences but are challenged by utilizing predominantly h ...
Full textLink to itemCite
Journal ArticleFront Oncol · 2022
BACKGROUND: Cervical cancer (CC) is more prevalent in women living with human immunodeficiency virus (HIV) infection compared to the general population. The magnitude is high among all countries burdened with HIV-Tanzania is no exception. Despite the unpre ...
Full textLink to itemCite
Journal ArticleGlobal Health Journal · June 1, 2021
Background: Missed clinic appointments negatively impact clinic patient flow and health outcomes of people living with HIV (PLHIV). PLHIV likelihood of missing clinic appointments is associated with direct and indirect expenditures made while accessing HIV ...
Full textOpen AccessCite
Journal ArticleBMC Med Educ · March 17, 2021
BACKGROUND: Sustainability of research culture in Sub-Saharan Africa is threatened in part by the lack of a critical mass of young researchers with the requisite skills and interest to undertake research careers. This paper describes an intensive mentorshi ...
Full textLink to itemCite
Journal ArticleGlob Heart · January 18, 2021
BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death and disability worldwide. Health research is crucial to managing disease burden. Previous work has highlighted marked discrepancies in research output and disease burden between high-in ...
Full textLink to itemCite
Journal ArticleHIV AIDS Research and Palliative Care · January 1, 2021
Purpose: Cardiovascular disease (CVD) risk assessment is a suitable way to differentiate between high-risk individuals requiring intervention and risk modification, and those at low risk. However, concerns have been raised when adopting a CVD-risk predicti ...
Full textCite
Journal ArticlePatient Prefer Adherence · 2021
INTRODUCTION: Prevention of mother-to-child transmission (PMTCT) remains a cornerstone of HIV prevention and control efforts. It is vital that the beneficiaries of PMTCT programs understand PMTCT recommendations, especially since their adherence to recomme ...
Full textLink to itemCite
Journal ArticleInfect Drug Resist · 2021
BACKGROUND: Bacterial urinary tract infection (BUTI) is the commonest urinary tract infection among people living with human immunodeficiency virus (PLHIV). It causes significant morbidity in this vulnerable group. Immunosuppression due to HIV can mask the ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · August 18, 2020
Background Evidence suggests that acute coronary syndrome (ACS) is underdiagnosed in sub-Saharan Africa. Triage-based interventions have improved ACS diagnosis and management in high-income settings but have not been evaluated in sub-Saharan African emerge ...
Full textLink to itemCite
Journal ArticleJ Cancer Educ · August 2020
An important component of cancer control programs for the growing burden in sub-Saharan Africa is a population's awareness of risk factors. Studies thereof have focused on single rather than multiple cancers and carcinogens. During March and April 2015, we ...
Full textLink to itemCite
Journal ArticleAm Heart J · August 2020
BACKGROUND: Growing evidence suggests that under-diagnosis of acute myocardial infarction (AMI) may be common in sub-Saharan Africa. Prospective studies of routine AMI screening among patients presenting to emergency departments in sub-Saharan Africa are l ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Pediatr Hematol Oncol · January 2020
OBJECTIVE: We aimed to establish the prevalence of human immunodeficiency virus (HIV)-associated malignancies in children attending a care and treatment clinic at Kilimanjaro Christian Medical Centre. MATERIALS AND METHODS: This was a retrospective cross-s ...
Full textLink to itemCite
Journal ArticlePatient Prefer Adherence · 2020
INTRODUCTION: Despite improvements in treatment (eg, reduction in pill intake), antiretroviral therapy (ART) is dispensed in socially inefficient and uneconomical packaging. To make pills less conspicuous and decrease the risk of being stigmatized, people ...
Full textOpen AccessLink to itemCite
Journal ArticleCancer Treat Res Commun · 2020
BACKGROUND: Although the burden of human immunodeficiency virus (HIV) infection in Tanzania is high, limited data are available on cancers in HIV-infected patients. We aimed to determine the spectrum and prevalence of cancers in HIV-infected patients atten ...
Full textLink to itemCite
Journal ArticleAfr J Emerg Med · December 2019
INTRODUCTION: The prevalence of cardiovascular disease in sub-Saharan Africa is substantial and growing. Much remains to be learned about the relative burden of acute coronary syndrome (ACS), heart failure, and stroke on emergency departments and hospital ...
Full textOpen AccessLink to itemCite
Journal ArticleInt J STD AIDS · December 2019
HIV prevention efforts have historically focused on people aged 15-49, despite mounting evidence of risk behavior and increased disease burden among older adults. We analyzed survey data from 600 adults ≥ 50 years in the Rombo District of Tanzania. Logisti ...
Full textLink to itemCite
Journal ArticleLife Sci · October 15, 2019
AIMS: We performed a systematic review and meta-analysis on the effect of HIV infection and antiretroviral therapy (ART) on carotid intima-media thickness (cIMT) to elucidate the role of HIV infection and ART. Also, an analysis on the role of ethnicity and ...
Full textLink to itemCite
Journal ArticleCancer · March 15, 2019
BACKGROUND: People with HIV (PWHIV) have improved survival because of the advent of antiretroviral therapy. Consequently, PWHIV experience higher rates of non-acquired immunodeficiency syndrome-defining malignancies (NADMs). Previous studies have demonstra ...
Full textLink to itemCite
Journal ArticleBMC Infect Dis · February 22, 2019
Following publication of the original article [1], the authors reported that they have provided the wrong caption. ...
Full textLink to itemCite
Journal ArticleBMC Infect Dis · December 29, 2018
BACKGROUND: Effective combined antiretroviral therapy (cART) has improved life expectancy among people living with HIV-1 infection. Treated HIV-1infection increases the prevalence of metabolic syndrome (MS). Despite sub-Saharan Africa having among the high ...
Full textLink to itemCite
Journal ArticleAIDS Behav · May 2018
Patient-initiated repackaging of antiretroviral therapy (ART) refers to removal of ART medications from their original manufacturer's containers, and putting them into alternative containers. This behavior may be triggered by stigma associated with HIV inf ...
Full textLink to itemCite
Journal ArticleAnn Glob Health · April 30, 2018
BACKGROUND: The shortage of medical doctors in sub-Saharan Africa (SSA) has resulted in increased enrolment in medical schools, which has not been matched with increased faculty size or physical infrastructure. This process has led to overcrowding and poss ...
Full textLink to itemCite
Journal IssueJ Am Med Inform Assoc · February 1, 2018
BACKGROUND: Electronic medical record (EMR) computed algorithms allow investigators to screen thousands of patient records to identify specific disease cases. No computed algorithms have been developed to detect all cases of human immunodeficiency virus (H ...
Full textLink to itemCite
Chapter · January 1, 2018
Antiretroviral therapy (ART) treatment has been proven to slow the progression of disease and reduce the risk of transmission for individuals with human immunodeficiency virus (HIV) infection. The goal of ART treatment is to completely inhibit viral replic ...
Cite
Journal ArticleAIDS Res Hum Retroviruses · November 2017
Prevention of mother-to-child transmission (PMTCT) guidelines recommend that all HIV-infected pregnant women receive antiretroviral therapy (Option B) and HIV-infected infants should initiate therapy with a protease inhibitor-based regimen; however, implem ...
Full textLink to itemCite
Journal ArticleAnn Glob Health · 2017
BACKGROUND: The Duke Global Health Institute (DGHI) was founded in 2006 with a goal to foster interdisciplinary global health education and research across Duke University and Duke Medical Center. Critical to achieving this goal is the need to develop and ...
Full textOpen AccessLink to itemCite
Journal ArticleAntivir Ther · 2017
BACKGROUND: Cardiovascular disease (CVD) is an emerging concern for HIV-infected patients. Hyperlipidaemia is a risk factor for CVD and a complication of protease-inhibitor-based antiretroviral therapy, but little is known about its incidence and risk fact ...
Full textLink to itemCite
Journal ArticlePLoS One · 2017
BACKGROUND: Antiretroviral therapy (ART) has been shown to reduce HIV-related morbidity and mortality amongst those living with HIV and reduce transmission of the virus to those who are yet to be infected. However, these outcomes depend on maximum ART adhe ...
Full textLink to itemCite
Journal ArticleArtery Research · December 1, 2016
Background HIV-1 infection in northern populations is associated with increased large artery stiffness, both in the absence and presence of combination antiretroviral treatment (cART). It is unclear if similar changes occur in sub-Sahara African HIV-infect ...
Full textCite
Journal ArticleOpen Forum Infect Dis · September 2016
Background.  The mechanism of virologic failure (VF) of lopinavir/ritonavir (LPV/r) monotherapy is not well understood. We assessed sequence changes in human immunodeficiency virus-1 reverse-transcriptase (RT) and protease (PR) regions. Methods.  Human imm ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · July 15, 2016
BACKGROUND: Previous studies suggest that nonnucleoside reverse-transcriptase inhibitors (NNRTIs) cause faster virologic suppression, while ritonavir-boosted protease inhibitors (PI/r) recover more CD4 cells. However, individual trials have not been powere ...
Full textLink to itemCite
Journal ArticleBMC Health Serv Res · July 15, 2016
BACKGROUND: Adherence to Antiretroviral Therapy (ART) is critical piece in the management of HIV infected patients. Despite the benefits of ART, non-adherence to ART persists. This study explores association between patient's knowledge of the ART line of t ...
Full textLink to itemCite
Journal ArticleBMC Med Educ · February 9, 2016
BACKGROUND: Mal-distribution of health care workers is a global health challenge that exacerbates health disparities, especially in resource-limited settings. Interventions to mitigate the problem have targeted qualified personnel with little focus on medi ...
Full textLink to itemCite
Journal ArticleJ Infect Dis · January 15, 2016
BACKGROUND: Virologic failure in subtype C is characterized by high resistance to first-line antiretroviral (ARV) drugs, including efavirenz, nevirapine, and lamivudine, with nucleoside resistance including type 2 thymidine analog mutations, K65R, a T69del ...
Full textLink to itemCite
Journal ArticleOpen Forum Infect Dis · January 2016
Background.  Due to the unintended potential misclassifications of the World Health Organization (WHO) immunological failure criteria in predicting virological failure, limited availability of treatment options, poor laboratory infrastructure, and healthca ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · May 15, 2015
BACKGROUND: The AIDS Clinical Trials Group (ACTG) A5230 study evaluated lopinavir/ritonavir (LPV/r) monotherapy following virologic failure (VF) on first-line human immunodeficiency virus (HIV) regimens in Africa and Asia. METHODS: Eligible subjects had re ...
Full textOpen AccessLink to itemCite
Journal ArticleAm J Trop Med Hyg · February 2015
We describe the laboratory-confirmed etiologies of illness among participants in a hospital-based febrile illness cohort study in northern Tanzania who retrospectively met Integrated Management of Adolescent and Adult Illness District Clinician Manual (IMA ...
Full textOpen AccessLink to itemCite
Journal ArticleInt J Dermatol · January 2015
Abnormal skin findings are identified in over 90% of human immunodeficiency virus (HIV)-infected persons globally. A prospective cohort study of HIV-infected patients with skin complaints commencing antiretroviral therapy (ART) in northern Tanzania was und ...
Full textOpen AccessLink to itemCite
Journal ArticleInfect Agent Cancer · 2015
BACKGROUND: Despite comparable screening rates for precancerous lesions, higher incidence and mortality related to cervical cancer in minority women persists. Recent evidence suggests that minority women with precancerous cervical lesions harbor a wider ra ...
Full textOpen AccessLink to itemCite
Journal ArticleInfect Dis Ther · December 2014
The integrase strand transfer inhibitors (INSTIs) are the newest antiretroviral class in the HIV treatment armamentarium. Dolutegravir (DTG) is the only second-generation INSTI with FDA approval (2013). It has potential advantages in comparison to first-ge ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · September 1, 2014
BACKGROUND: The development of drug resistance to nucleoside reverse transcriptase inhibitors (NRTIs) and nonnucleoside reverse transcriptase inhibitors (NNRTIs) has been associated with baseline human immunodeficiency virus (HIV)-1 RNA level (VL), CD4 cel ...
Full textLink to itemCite
Journal ArticleOpen Forum Infect Dis · September 2014
BACKGROUND: Adherence to first-line antiretroviral therapy (ART) may be an important indicator of adherence to second-line ART. Evaluating this relationship may be critical to identify patients at high risk for second-line failure, thereby exhausting their ...
Full textLink to itemCite
Journal ArticleAcad Med · August 2014
The Kilimanjaro Christian Medical University (KCMU) College and the Medical Education Partnership Initiative (MEPI) are addressing the crisis in Tanzanian health care manpower by modernizing the college's medical education with new tools and techniques. Wi ...
Full textLink to itemCite
Journal ArticleJ Clin Endocrinol Metab · June 2014
OBJECTIVE: Malnutrition is a major cause of childhood morbidity and mortality. To identify and target those at highest risk, there is a critical need to characterize biomarkers that predict complications prior to and during treatment. METHODS: We used targ ...
Full textLink to itemCite
Journal ArticleInfectious Agents and Cancer · May 20, 2014
Background: In low- and middle-income countries, the association between delay to treatment and prognosis for Kaposi's sarcoma (KS) patients is yet to be studied. Methods. This is a prospective study of HIV-infected adults with histologically-confirmed KS ...
Full textCite
Journal ArticleMed Teach · April 2014
BACKGROUND: Contemporary teaching in sub-Saharan African medical schools is largely through didactic and problem-based approaches. These schools face challenges from burgeoning student numbers, severe faculty shortages, faculty without instruction in teach ...
Full textLink to itemCite
Journal ArticleClinical and Translational Oncology · March 1, 2014
Introduction: Although most invasive cervical cancer (ICC) harbor <20 human papillomavirus (HPV) genotypes, use of HPV screening to predict ICC from HPV has low specificity, resulting in multiple and costly follow-up visits and overtreatment. We examined D ...
Full textCite
Journal ArticleClin Transl Oncol · March 2014
INTRODUCTION: Although most invasive cervical cancer (ICC) harbor <20 human papillomavirus (HPV) genotypes, use of HPV screening to predict ICC from HPV has low specificity, resulting in multiple and costly follow-up visits and overtreatment. We examined D ...
Full textLink to itemCite
Journal ArticleBMC Infect Dis · February 20, 2014
BACKGROUND: Routine tuberculosis culture remains unavailable in many high-burden areas, including Tanzania. This study sought to determine the impact of providing mycobacterial culture results over standard of care [unconcentrated acid-fast (AFB) smears] o ...
Full textOpen AccessLink to itemCite
Journal ArticleBMC Infectious Diseases · February 20, 2014
Background: Routine tuberculosis culture remains unavailable in many high-burden areas, including Tanzania. This study sought to determine the impact of providing mycobacterial culture results over standard of care [unconcentrated acid-fast (AFB) smears] o ...
Full textCite
Journal ArticlePLoS One · 2014
BACKGROUND: Mother to child transmission (MTCT) of HIV-1 remains an important problem in sub-Saharan Africa where most new pediatric HIV-1 infections occur. Early infant diagnosis of HIV-1 using dried blood spot (DBS) PCR among exposed infants provides an ...
Full textLink to itemCite
Journal ArticleWorld Health Popul · 2014
The projected cancer burden in Africa demands a comprehensive surveillance strategy. Kilimanjaro Christian Medical Centre (KCMC) is developing a population-based cancer registry, and understanding stakeholders' perceptions of factors impacting cancer regis ...
Full textLink to itemCite
Journal ArticlePLoS One · 2014
BACKGROUND: HIV infection occurs in 30% of children with severe acute malnutrition in sub-Saharan Africa. Effects of HIV on the pathophysiology and recovery from malnutrition are poorly understood. METHODS: We conducted a prospective cohort study of 75 sev ...
Full textLink to itemCite
Journal ArticleJ Assoc Nurses AIDS Care · 2014
Blacks living in the southern United States are disproportionately affected by HIV infection. Identifying and treating those who are infected is an important strategy for reducing HIV transmission. A model for integrating rapid HIV screening into community ...
Full textLink to itemCite
Journal ArticleClin Radiol · October 2013
AIM: To describe chest radiographic abnormalities and assess their usefulness for predicting causes of fever in a resource-limited setting. MATERIALS AND METHODS: Febrile patients were enrolled in Moshi, Tanzania, and chest radiographs were evaluated by ra ...
Full textLink to itemCite
Journal ArticleJ Clin Invest · September 2013
A 29-year-old man with recently diagnosed HIV infection and a CD4 cell count of 225/mm³ began treatment with atazanavir (300 mg), ritonavir (100 mg), emtricitabine (200 mg), and tenofovir (300 mg) daily. For 18 months, he was treatment adherent and his pla ...
Full textLink to itemCite
Journal ArticlePLoS One · 2013
Cytology-based screening for invasive cervical cancer (ICC) lacks sensitivity and specificity to discriminate between cervical intraepithelial neoplasia (CIN) likely to persist or progress from cases likely to resolve. Genome-wide approaches have been used ...
Full textLink to itemCite
Journal ArticleWorld Health Popul · 2013
Cancer burden is increasing in Africa more than in any other continent, but population-based tracking of cancer incidence is incomplete. Cancer registries can improve understanding of cancer incidence. To assess organizational readiness to sustain registry ...
Full textLink to itemCite
Journal ArticlePLoS Negl Trop Dis · 2013
INTRODUCTION: The syndrome of fever is a commonly presenting complaint among persons seeking healthcare in low-resource areas, yet the public health community has not approached fever in a comprehensive manner. In many areas, malaria is over-diagnosed, and ...
Full textOpen AccessLink to itemCite
Journal ArticleAm J Trop Med Hyg · December 2012
Acute and convalescent serum samples were collected from febrile inpatients identified at two hospitals in Moshi, Tanzania. Confirmed brucellosis was defined as a positive blood culture or a ≥ 4-fold increase in microagglutination test titer, and probable ...
Full textOpen AccessLink to itemCite
Journal ArticleAIDS · July 17, 2012
OBJECTIVE: To evaluate virologic response rates of lopinavir/ritonavir (LPV/r) monotherapy as second-line antiretroviral treatment (ART) among adults in resource-limited settings (RLSs). DESIGN: An open-label pilot study of LPV/r monotherapy in participant ...
Full textOpen AccessLink to itemCite
Journal ArticleClin Infect Dis · July 2012
BACKGROUND: Disseminated tuberculosis is a major health problem in countries where generalized human immunodeficiency virus (HIV) infection epidemics coincide with high tuberculosis incidence rates; data are limited on patient outcomes beyond the inpatient ...
Full textOpen AccessLink to itemCite
Journal ArticleAm J Trop Med Hyg · January 2012
Consecutive febrile admissions were enrolled at two hospitals in Moshi, Tanzania. Confirmed acute Chikungunya virus (CHIKV), Dengue virus (DENV), and flavivirus infection were defined as a positive polymerase chain reaction (PCR) result. Presumptive acute ...
Full textOpen AccessLink to itemCite
Journal ArticleInfect Agent Cancer · November 14, 2011
BACKGROUND: Infection with human papillomavirus (HPV) is associated with uterine cervical intraepithelial neoplasia (CIN) and invasive cancers (ICC). Approximately 80% of ICC cases are diagnosed in under-developed countries. Vaccine development relies on k ...
Full textOpen AccessLink to itemCite
Journal ArticleAm J Trop Med Hyg · August 2011
We enrolled consecutive febrile admissions to two hospitals in Moshi, Tanzania. Confirmed leptospirosis was defined as a ≥ 4-fold increase in microscopic agglutination test (MAT) titer; probable leptospirosis as reciprocal MAT titer ≥ 800; and exposure to ...
Full textOpen AccessLink to itemCite
Journal ArticleClin Infect Dis · August 2011
BACKGROUND: The importance of Q fever, spotted fever group rickettsiosis (SFGR), and typhus group rickettsiosis (TGR) as causes of febrile illness in sub-Saharan Africa is unknown; the putative role of Q fever as a human immunodeficiency virus (HIV) coinfe ...
Full textLink to itemCite
Journal ArticleTrop Med Int Health · July 2011
OBJECTIVE: To describe the contribution of paediatric HIV and of HIV co-infections to admissions to a hospital in Moshi, Tanzania, using contemporary laboratory methods. METHODS: During 1 year, we enrolled consecutively admitted patients aged ≥2 months and ...
Full textLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr · April 15, 2011
BACKGROUND: Guidelines in sub-Saharan Africa on when HIV-seronegative persons should retest range from never to annually for lower-risk populations and from annually to every 3 months for high-risk populations. METHODS: We designed a mathematical model to ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · February 1, 2011
BACKGROUND: few studies describe patterns of human immunodeficiency virus (HIV) co-infections in African hospitals in the antiretroviral therapy (ART) era. METHODS: we enrolled consecutive admitted patients aged ≥ 13 years with oral temperature of ≥ 38.0°C ...
Full textLink to itemCite
Journal ArticlePLoS One · January 31, 2011
BACKGROUND: Optimally, expanded HIV testing programs should reduce barriers to testing while attracting new and high-risk testers. We assessed barriers to testing and HIV risk among clients participating in mobile voluntary counseling and testing (MVCT) ca ...
Full textOpen AccessLink to itemCite
Journal ArticleN C Med J · 2011
BACKGROUND: Durham County, North Carolina, faces high rates of human immunodeficiency virus (HIV) infection (with or without progression to AIDS) and sexually transmitted diseases (STDs). We explored the use of health care services and the prevalence of co ...
Open AccessLink to itemCite
Journal ArticleTrop Med Int Health · September 2010
OBJECTIVE: To determine the normal haematological and immunological reference intervals for healthy Tanzanian children. METHODS: We analysed data from 655 HIV-seronegative, healthy children from 1 month to 18 years of age from the Kilimanjaro Region of Tan ...
Full textLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr · August 2010
BACKGROUND: Many HIV care and treatment programs in resource-limited settings rely on clinical and immunologic monitoring of antiretroviral therapy (ART), but accuracy of this strategy to detect virologic failure (VF) among children has not been evaluated. ...
Full textOpen AccessLink to itemCite
Journal ArticleHIV Med · August 2010
BACKGROUND: This study examines the association between microalbuminuria and the development of proteinuria among HIV-infected persons. METHODS: A total of 948 subjects provided urine samples for albumin, protein and creatinine measurements semiannually. M ...
Full textLink to itemCite
Journal ArticleAIDS Res Hum Retroviruses · December 2009
Fixed dose combination abacavir/lamivudine/zidovudine (ABC/3TC/ZDV) among HIV-1 and tuberculosis (TB)-coinfected patients was evaluated and outcomes between early vs. delayed initiation were compared. In a randomized, pilot study conducted in the Kilimanja ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr · December 2009
OBJECTIVES: We evaluated changes in characteristics of clients presenting for voluntary counseling and testing (VCT) before and during care and treatment center (CTC) scale-up activities in Moshi, Tanzania, between November 2003 and December 2007. METHODS: ...
Full textLink to itemCite
Journal ArticleAIDS · November 27, 2009
OBJECTIVE: To assess technical and operational performance of a dried blood spot (DBS)-based HIV-1 RNA service for remote healthcare facilities in a low-income country. DESIGN: A method comparison and operational evaluation of DBS RNA against conventional ...
Full textLink to itemCite
Journal ArticleInt J Tuberc Lung Dis · October 2009
SETTING: A community-based voluntary counseling and testing (VCT) center in Moshi, Tanzania. OBJECTIVE: To compare rates of prior human immunodeficiency virus (HIV) testing among clients with and without previous tuberculosis (TB) treatment, and HIV seropo ...
Link to itemCite
Journal ArticleLancet Infect Dis · October 2009
As a result of the scale-up of antiretroviral treatment (ART) programmes and substantial financial support worldwide, an increasing number of HIV-infected individuals in low-income and middle-income countries (LIMCs) now have access to ART. Despite this pr ...
Full textLink to itemCite
Journal ArticleAnn Trop Med Parasitol · April 2009
Community home-based care (CHBC) plays an integral role in the care of HIV-infected patients living in resource-limited regions. A longitudinal cohort study has recently been conducted, in the Kilimanjaro Region of northern Tanzania, in order to identify t ...
Full textLink to itemCite
Journal ArticleAIDS Res Hum Retroviruses · February 2009
Some patients are unable to achieve and maintain an undetectable plasma HIV-1 RNA level with combination antiretroviral therapy (ART) and are therefore maintained on a partially suppressive regimen. To determine the immune consequences of continuing ART de ...
Full textLink to itemCite
Chapter · January 1, 2009
While remarkable therapeutic advances have prolonged the lives of many people infected with HIV, the HIV pandemic continues to expand, particularly in the most impoverished regions of the world. By the end of 2005, there were approximately 40 million peopl ...
Cite
Journal ArticleEmerg Infect Dis · January 2009
Data on nontuberculous mycobacterial (NTM) disease in sub-Saharan Africa are limited. During 2006-2008, we identified 3 HIV-infected patients in northern Tanzania who had invasive NTM; 2 were infected with "Mycobacterium sherrisii" and 1 with M. avium comp ...
Full textLink to itemCite
Journal ArticleJ Int Assoc Physicians AIDS Care (Chic) · 2009
More than 3 million people were receiving antiretroviral therapy (ART) at the end of 2007, but this number represents only 31% of people clinically eligible for ART in resource-limited settings. The primary objective of this study is to summarize the key o ...
Full textLink to itemCite
Journal ArticleEast Afr Med J · September 2008
OBJECTIVE: To evaluate the performance of QuantiFERON-TB GOLD (QFTG) in a resource-poor setting among patients with and without HIV infection. DESIGN: Cross-sectional study. SETTING: Two hospitals in Northern Tanzania. SUBJECTS: Eighty three adult male and ...
Full textLink to itemCite
Journal ArticlePLoS One · August 27, 2008
BACKGROUND: Monogamy, together with abstinence, partner reduction, and condom use, is widely advocated as a key behavioral strategy to prevent HIV infection in sub-Saharan Africa. We examined the association between the number of sexual partners and the ri ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr · April 15, 2008
BACKGROUND: Trimethoprim-sulfamethoxazole (SXT) reduces morbidity and mortality among HIV-infected persons in Africa, but its impact on antimicrobial resistance is of concern. METHODS: HIV-uninfected (group A), HIV-infected but not requiring SXT (group B), ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · December 1, 2007
BACKGROUND: Access to antiretroviral therapy is rapidly expanding in sub-Saharan Africa. Identifying the predictors of incomplete adherence, virologic failure, and antiviral drug resistance is essential to achieving long-term success. METHODS: A total of 1 ...
Full textLink to itemCite
Journal ArticleAIDS Res Hum Retroviruses · October 2007
Clinical criteria are recommended to select HIV-infected patients for initiation of antiretroviral therapy when CD4 lymphocyte testing is unavailable. We evaluated the performance characteristics of WHO staging criteria, anthropometrics, and simple laborat ...
Full textLink to itemCite
Journal ArticleJ Int Assoc Physicians AIDS Care (Chic) · March 2007
Antiretroviral treatment literacy leads to greater HIV testing and treatment and antiretroviral treatment adherence. Among northern Tanzanian subjects, antiretroviral treatment awareness was only 17%. Factors associated with low antiretroviral treatment li ...
Full textLink to itemCite
Journal ArticleJ Int Assoc Physicians AIDS Care (Chic) · March 2007
HIV/AIDS care has benefited tremendously from the availability of antiretroviral (ARV) drugs, both branded and generic. Drug discovery and innovation is the result of direct investment in the development of branded medications, a crucial process for future ...
Full textLink to itemCite
Journal ArticleNat Methods · February 2007
We developed a highly sensitive parallel allele-specific sequencing (PASS) assay to simultaneously analyze a large number of viral genomes and detect minor drug-resistant populations at approximately 0.1-0.01% levels. Using this assay on samples from indiv ...
Full textLink to itemCite
Journal ArticleAntivir Ther · 2007
BACKGROUND: Suboptimal improvement in CD4+ T-cell count is not uncommon in HIV-infected patients with suppressed plasma HIV RNA levels, and a decrease in CD4+ T-cell count in patients with suppressed or low-level viraemia has been observed. METHODS: Our ob ...
Link to itemCite
Journal ArticleHIV Clin Trials · 2007
BACKGROUND: Many trials of antiretroviral therapy in treatment-naïve subjects have investigated the relative efficacy of the third drug in a treatment regimen. However, the nucleoside/nucleotide reverse transcriptase inhibitor (NRTI) components may also af ...
Full textLink to itemCite
Journal ArticleAntivir Ther · 2007
BACKGROUND: Clinical stability has been observed with continued antiretroviral therapy (ART) in the setting of partial virological suppression. The optimal time to switch treatment in patients with low but detectable HIV-1 RNA is not known. METHODS: Subjec ...
Full textLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr · November 1, 2006
OBJECTIVE: To compare alternative class-sparing antiretroviral regimens in treatment-naive subjects. DESIGN: Open-label, multicenter, randomized trial of up to 3 consecutive treatment regimens over 96 weeks. METHODS: Two hundred ninety-one subjects receive ...
Full textLink to itemCite
Journal ArticleAIDS · October 24, 2006
OBJECTIVE: To compare the effectiveness of three drug combination antiretroviral therapy (ART) in treatment-naive HIV-infected persons, and identify the predictors of responses. DESIGN AND METHODS: Overview of trials identified by searching public domain p ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · September 15, 2006
Associations have been reported between an MDR1 variant and responses to nonnucleoside reverse-transcriptase inhibitors. We explored associations between MDR1, CYP2B6, and CYP3A polymorphisms and nevirapine hepatotoxicity. Among participants in a randomize ...
Full textLink to itemCite
Journal ArticleCurr HIV/AIDS Rep · July 2006
Virologic relapse after initial virologic suppression remains a concern for patients on antiretroviral therapy (ART). Multiple factors may contribute to virologic relapse, including suboptimal adherence, resistance, and pharmacokinetic issues. The major gu ...
Full textLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr · March 2006
OBJECTIVE: To identify optimal first-line therapies based on the rate of virologic success (VS) and the preservation of future treatment options in antiretroviral therapy (ART)-naive subjects. DESIGN: Systematic overview of genotypic resistance mutations f ...
Full textLink to itemCite
Journal ArticleAm J Public Health · January 2006
OBJECTIVES: We evaluated the cost-effectiveness of fee-based and free testing strategies at an HIV voluntary counseling and testing (VCT) program integrated into a community-based AIDS service organization in Moshi, Tanzania. METHODS: We waived the usual f ...
Full textLink to itemCite
Journal ArticleAntivir Ther · 2006
OBJECTIVE: Antiretroviral regimens containing the fusion inhibitor enfuvirtide (ENF) are associated with sustained viral suppression and immunological benefit. However, local injection site reactions (ISR) occur in the majority of patients. The aim of this ...
Link to itemCite
Journal ArticleExpert Rev Anti Infect Ther · December 2005
The fixed dose combination of abacavir with lamivudine represents a new treatment option for patients infected with HIV. Fixed dose combination abacavir/lamivudine has the convenience of one pill and once-daily dosing. It achieves comparable suppression of ...
Full textLink to itemCite
Journal ArticleInt J STD AIDS · October 2005
HIV voluntary counselling and testing (VCT) reduces high-risk sexual behaviour. Factors associated with HIV infection in VCT clients have not been well characterized in northern Tanzania. We prospectively surveyed 813 VCT clients in Moshi, Tanzania. Client ...
Full textLink to itemCite
Journal ArticleJ Clin Immunol · September 2005
A key determinant of T cell dynamics in HIV-1 infection is the status of thymic function. To date, most studies of the impact of HIV-1 on the thymus during early HIV-1 infection have been done in samples collected in the interval of 3-12 months after infec ...
Full textLink to itemCite
Journal ArticleJ Infect Dis · March 15, 2005
Human immunodeficiency virus (HIV)-infected South African patients (n=468) received blinded lamivudine or emtricitabine, stavudine, and either nevirapine or efavirenz (based on screening viral load). Baseline characteristics were analyzed in univariate and ...
Full textLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr · December 15, 2004
Antiretroviral (ARV) treatment decisions are difficult for HIV-1-infected patients on complex treatment regimens who have partial suppression of HIV-1 replication and limited treatment options. Information on the ARV activity of the components of a complex ...
Full textLink to itemCite
Journal ArticleAIDS · May 21, 2004
We examined the safety and immunogenicity of a human leukocyte antigen-based HIV envelope polyvalent synthetic peptide vaccine, C4-V3, alone and in combination with subcutaneous IL-12 in nine HIV-infected patients. Lymphocyte proliferative responses increa ...
Full textLink to itemCite
Journal ArticleJ Infect Dis · March 15, 2004
T-1249 is a 39-aa synthetic peptide that inhibits fusion of human immunodeficiency virus (HIV) to the host target cell. A 14-day open-label, phase 1/2 dose-escalation monotherapy study of the safety and antiretroviral activity of T-1249 was performed on 11 ...
Full textLink to itemCite
Journal ArticleAnn Trop Med Parasitol · March 2004
Hospitalized patients with HIV infection are among the most likely to benefit from the expanding availability of anti-retroviral therapy in sub-Saharan Africa. Between 1990 and 2000, 3667 people known to be HIV-infected were admitted to Kilimanjaro Christi ...
Full textLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr · December 15, 2003
Markers of maturation and activation were measured on peripheral CD4+ T cells in chronically HIV-1-infected patients in a randomized, controlled pilot study of structured treatment interruption (STI). Eight subjects underwent 2 cycles of 1 month off and 1 ...
Full textLink to itemCite
Journal ArticleAIDS · November 22, 2002
We report the emergence of drug-resistant viral mutations in chronically HIV-infected individual undergoing structured treatment interruptions (STI). THe protease mutations K101E and K103N were detected at the end of the second or third STI. We concluded t ...
Full textLink to itemCite
Journal ArticleJ Infect Dis · October 1, 2002
Filgrastim, or granulocyte colony-stimulating factor, reverses neutropenia associated with human immunodeficiency virus type 1 (HIV-1) and cytomegalovirus (CMV) infections. During a trial of anti-CMV retinitis therapies coadministered with antiretroviral t ...
Full textLink to itemCite
Journal ArticleAIDS Res Hum Retroviruses · May 20, 2002
The chronically HIV-infected cellular reservoir in lymphoid tissue (LT) represents a formidable obstacle to the long-term success of antiretroviral therapy. Cytoreductive chemotherapy with cyclophosphamide (CTX) reduces cells in LT, and we hypothesized tha ...
Full textLink to itemCite
Journal ArticleClin Nephrol · May 2002
AIMS: While angiotensin-con-verting enzyme inhibitors and zidovudine may improve the course of the most common HIV-related renal disease, HIV-associated nephropathy (HIVAN), the effect of anti-retroviral combination therapy on this and other HIV-related re ...
Full textLink to itemCite
Journal ArticleJ Am Geriatr Soc · April 2002
OBJECTIVES: To determine the effect of antiretroviral therapy (ART) on the immunological and virological outcomes of older human immunodeficiency virus (HIV)-infected patients compared with younger HIV-infected patients. DESIGN: Matched (1:2) retrospective ...
Full textLink to itemCite
Journal ArticleAIDS · February 15, 2002
OBJECTIVE: To determine if there is an association between plasma HIV-1 RNA levels and severity of HIV-associated distal symmetrical polyneuropathy (DSP). DESIGN: Substudy of AIDS Clinical Trials Group Protocol 291, a double-blind, placebo-controlled study ...
Full textLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr · February 1, 2002
Adherence to antiretroviral therapy is a crucial determinant of treatment success. Studies have unequivocally demonstrated the close association between adherence and plasma HIV RNA levels, CD4 cell counts, and mortality in patients with HIV infection and ...
Full textLink to itemCite
Journal ArticleKidney Int · January 2002
BACKGROUND: Glomerular disease with proteinuria and renal failure are complications of human immunodeficiency virus (HIV) infection. While studies suggest risk factors for both include black race and lower CD4 lymphocyte count, they have not been establish ...
Full textLink to itemCite
Journal ArticleAIDS Res Hum Retroviruses · November 20, 2001
The thymus of HIV-seropositive patients can enlarge as CD4+ T cell counts increase on highly active anti-retroviral therapy (HAART). This may indicate development of new T cells or represent mature peripheral T cells recirculating to the thymus. To define ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · November 6, 2001
The risks and benefits of structured treatment interruption (STI) in HIV-1-infected subjects are not fully understood. A pilot study was performed to compare STI with continuous highly active antiretroviral therapy (HAART) in chronic HIV-1-infected subject ...
Full textLink to itemCite
Journal ArticleJ Gen Intern Med · September 2001
OBJECTIVE: To measure the impact of a teaching intervention and to compare process and outcomes of care for HIV-infected patients randomly assigned to a general medicine clinic (GMC) or an infectious disease clinic (IDC) for primary care. DESIGN: Prospecti ...
Full textLink to itemCite
Journal ArticleAIDS · July 27, 2001
AIM: To estimate the effectiveness of triple combination therapy in antiretroviral-naive adults. METHODS: A systematic overview of results from clinical trials involving triple combination therapy with dual nucleoside reverse transcriptase inhibitors (NRTI ...
Full textLink to itemCite
Journal ArticleJ Infect Dis · May 15, 2001
A dissociation between plasma human immunodeficiency virus (HIV) RNA levels and CD4(+) cell counts has been reported in patients experiencing viral relapse while receiving antiretroviral therapy. This study compared patients with stable CD4(+) lymphocytes ...
Full textLink to itemCite
Journal ArticleAIDS Res Hum Retroviruses · August 10, 2000
OBJECTIVE: To evaluate treatment-mediated changes in HIV-1 RNA and CD4 count as prognostic markers and surrogate end points for disease progression (AIDS/death). METHODS: Data from 13,045 subjects in all 16 randomized trials comparing nucleoside analogue r ...
Full textLink to itemCite
Journal ArticleAIDS Res Hum Retroviruses · March 20, 2000
The purpose of this study was to determine whether thymic transplantation in addition to highly active antiretroviral therapy (HAART) will restore T cell function in HIV infection. Eight treatment-naive HIV-infected patients with CD4+ T cell counts of 200- ...
Full textLink to itemCite
Journal ArticleEmerg Infect Dis · 2000
We describe the first reported case of meningococcemia in a patient coinfected with hepatitis C virus and HIV. Hypocomplementemia secondary to hepatic dysfunction may have enhanced the patient's susceptibility to meningococcal infection. ...
Full textOpen AccessLink to itemCite
Journal ArticleAntimicrob Agents Chemother · December 1999
Lamivudine population pharmacokinetics were investigated by using nonlinear mixed-effect modelling (NONMEM) analysis of data from 394 human immunodeficiency virus (HIV)-infected patients treated with lamivudine (150 to 300 mg every 12 h) in two large, phas ...
Full textLink to itemCite
Journal ArticleUrol Clin North Am · November 1999
Recent progress in antiretroviral treatment has led to dramatic improvements in HIV-related morbidity and mortality. These improvements have been fostered by advances in our understanding of HIV-related pathogenesis, the use of plasma HIV RNA levels to mon ...
Full textLink to itemCite
Journal ArticleJ Clin Invest · February 1999
A key question in understanding the status of the immune system in HIV-1 infection is whether the adult thymus contributes to reconstitution of peripheral T lymphocytes. We analyzed the thymus in adult patients who died of HIV-1 infection. In addition, we ...
Full textLink to itemCite
Journal ArticleHosp Pract (1995) · December 15, 1998
Four cases illustrate some of the issues involved in treating HIV-infected patients in a primary care setting. Primary care physicians are hard-pressed to achieve the same results as infectious disease specialists, yet are increasingly responsible for perf ...
Full textLink to itemCite
Journal ArticleJ Infect Dis · December 1998
Plasma human immunodeficiency virus (HIV) RNA levels correlate closely with clinical prognosis in both treated and untreated HIV-infected persons and are widely used to guide clinical practice and as a primary end point in clinical trials. Thus, variabilit ...
Full textLink to itemCite
Journal ArticleJ Infect Dis · October 1998
Interleukin-2 (IL-2) can increase numbers of absolute CD4 cells in persons infected with the human immunodeficiency virus who are receiving antiretroviral therapy. Twenty-five subjects with > 400/mm3 absolute CD4 cells received zidovudine and low-dose intr ...
Full textLink to itemCite
Journal ArticleJ Surg Res · October 1998
Lymphocytes from HIV-1-seropositive and -seronegative individuals were examined to determine whether HIV-1 infection interfered with the ability to generate a lymphokine-activated killer (LAK) cell response. Following a 3-day ex vivo incubation in the pres ...
Full textLink to itemCite
Journal ArticleAIDS · July 30, 1998
OBJECTIVE: To evaluate the safety and immunogenicity of a polyvalent (PV) HIV envelope synthetic peptide immunogen, C4-V3. The immunogen comprised four peptides containing T-helper epitopes from the fourth constant region (C4) of gp120 of HIV-1MN, and T-he ...
Full textLink to itemCite
Journal ArticleOncologist · 1998
Recent progress in antiretroviral treatment has led to dramatic improvements in HIV-related morbidity and mortality. These improvements have been fostered by advances in our understanding of HIV-related pathogenesis, the use of plasma HIV RNA levels to mon ...
Link to itemCite
Journal ArticleJ Infect Dis · January 1998
Previous uncontrolled reports have suggested that H2-antagonists may possess immunomodulatory activity in human immunodeficiency virus (HIV)-infected patients. Such trials reported improvements in HIV-related symptoms, increased absolute CD4 cell numbers, ...
Full textLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr Hum Retrovirol · October 1, 1997
PURPOSE: To study the efficacy and safety of maintenance treatment with itraconazole for disseminated histoplasmosis in patients with AIDS. PATIENTS AND METHODS: This was a prospective, multicenter, open-label study conducted at university-based hospitals ...
Full textLink to itemCite
Journal ArticleBlood · September 15, 1997
In the attempt to develop immunotherapeutic strategies for acquired immunodeficiency syndrome capable of activating effector cells in an antigen-specific manner while maintaining the broadest possible T-cell repertoire, we evaluated two canarypox (ALVAC)-b ...
Link to itemCite
Journal ArticleClin Infect Dis · July 1997
Extrapulmonary involvement with Pneumocystis carinii has been described in 0.5%-2.5% of persons with AIDS. One hundred nine patients with AIDS and confirmed extrapulmonary pneumocystosis were identified, and seven of these patients (including our patients) ...
Full textLink to itemCite
Journal ArticleAIDS · March 15, 1997
OBJECTIVES: Four randomized double-blind trials have demonstrated that zidovudine/lamivudine (ZDV/3TC) reduces HIV RNA and raises CD4 counts relative to control treatments (ZDV or ZDV/zalcitabine (ddC)]. A meta-analysis of the clinical events in these trai ...
Full textLink to itemCite
Journal ArticleAIDS · February 1997
OBJECTIVES: To investigate whether apparently beneficial changes in plasma HIV RNA level and CD4 lymphocyte count that are induced by antiretroviral therapy are associated with a corresponding clinical benefit. METHODS: For 620 patients in two randomized, ...
Full textLink to itemCite
Journal ArticleAntimicrob Agents Chemother · December 1996
5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83) is a nucleoside analog reverse transcriptase inhibitor that has demonstrated selective anti-human immunodeficiency virus (HIV) activity in vitro and favorable safety profiles in monkeys and mice. A phase I s ...
Full textLink to itemCite
Journal ArticleAnn Intern Med · August 1, 1996
OBJECTIVE: To compare the safety and activity of lamivudine plus zidovudine with the safety and activity of zalcitabine plus zidovudine in patients with moderately advanced human immunodeficiency virus (HIV) infection who had received zidovudine. DESIGN: A ...
Full textLink to itemCite
Journal ArticleAIDS · July 1996
OBJECTIVE: To assess the prognostic value of HIV RNA levels for predicting clinical disease independently of the CD4 lymphocyte count in patients on antiretroviral therapy. DESIGN: Cohort of HIV-infected patients from two trials of lamivudine therapy. PATI ...
Full textLink to itemCite
Journal ArticleAntimicrob Agents Chemother · June 1996
The purpose of this study was to determine the safety and pharmacokinetics of lamivudine (3TC), a nucleoside analog that has shown potent in vitro and recent in vivo activity against human immunodeficiency virus. Sixteen human immunodeficiency virus-infect ...
Full textLink to itemCite
Journal ArticleJ Infect Dis · April 1996
Initiation of antiretroviral monotherapy early in the course of infection with human immunodeficiency virus may result in a temporary slowing in the rate of disease progression; however, little is known about the virologic effects of early therapy. Virus l ...
Full textLink to itemCite
Journal ArticleInt J Antimicrob Agents · April 1996
RMP-7, a nine-amino acid bradykinin analogue, has been shown in animals to temporarily increase the permeability of the blood brain barrier to small molecules including amphotericin B, when administered intravenously. We sought to evaluate the safety of es ...
Full textLink to itemCite
Journal ArticleAIDS · March 1996
OBJECTIVE: To examine the impact of continuous versus intermittent fluconazole therapy on fungal colonization and fluconazole resistance in the oropharynx of HIV-infected patients. DESIGN: Case-control study. SETTING: Duke University Adult Infectious Disea ...
Full textLink to itemCite
Journal ArticleInt J STD AIDS · 1996
To determine if positron emission tomography (PET) imaging using F-18 fluorodeoxyglucose (FDG) can accurately distinguish between malignant and infectious central nervous system (CNS) mass lesions in patients with human immunodeficiency virus (HIV) infecti ...
Full textLink to itemCite
Journal ArticleClin Exp Immunol · August 1995
CD8+ cytotoxic T lymphocytes are an important component in the immunologic control of human viral diseases. IL-7, a stromal cell-derived cytokine, has been demonstrated to enhance both anti-tumour and anti-viral CTL as well as lymphokine-activated killer ( ...
Full textLink to itemCite
Journal ArticlePhysiol Behav · August 1995
Human immunodeficiency virus (HIV-1) associated wasting is an increasingly common clinical manifestation of AIDS. The pathogenesis of wasting is multifactorial and includes reduced caloric intake as a major contributing mechanism. The perceptions of taste ...
Full textLink to itemCite
Journal ArticleAIDS · July 1995
OBJECTIVE: To determine if serologic marker responses to zidovudine treatment during the first year of antiretroviral therapy could predict subsequent HIV disease progression independently of absolute CD4 lymphocyte responses. METHODS: We conducted a case- ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · June 20, 1995
Although several immunologic and virologic markers measured in peripheral blood are useful for predicting accelerated progression of human immunodeficiency virus (HIV) disease, their validity for evaluating the response to antiretroviral therapy and their ...
Full textLink to itemCite
Journal ArticleAm J Med · April 1995
PURPOSE: Amphotericin B has been the treatment of choice for disseminated histoplasmosis in patients with acquired immunodeficiency syndrome (AIDS). Oral antifungal agents would be welcome alternatives to standard treatment of disseminated histoplasmosis i ...
Full textLink to itemCite
Journal ArticleAnn Intern Med · January 1, 1995
OBJECTIVE: To compare the safety and efficacy of continuing zidovudine therapy with that of zalcitabine alone or zalcitabine and zidovudine used together. DESIGN: A randomized, double-blind, controlled trial. SETTING: AIDS Clinical Trials units and Nationa ...
Full textLink to itemCite
Journal ArticleJAMA · August 10, 1994
OBJECTIVE: To determine the durability of zidovudine-induced delay in clinical progression of asymptomatic human immunodeficiency virus (HIV) disease and to assess the relationship between this effect and the entry CD4+ cell count. DESIGN AND INTERVENTIONS ...
Link to itemCite
Journal ArticleExpert Opinion on Investigational Drugs · August 1, 1994
The controversy surrounding the use of early versus delayed zidovudine therapy has created a contentious debate among clinical investigators, practitioners and their patients. The theoretical basis for antiretroviral therapy derives from the importance of ...
Full textCite
Journal ArticleAntimicrob Agents Chemother · April 1994
Levofloxacin, the bacteriologically active isomer of ofloxacin, has microbiologic activity against many pathogens common in human immunodeficiency virus (HIV)-infected patients, including Mycoplasma species which may be cofactors in the progression of HIV ...
Full textLink to itemCite
Journal ArticlePharmacotherapy · 1994
STUDY OBJECTIVE: To investigate the effect of simultaneously administered didanosine (ddI) on the absorption of a single dose of itraconazole. DESIGN: Randomized, crossover, unblinded single-dose pharmacokinetic study in healthy volunteers. Comparisons of ...
Link to itemCite
Journal ArticleAIDS Res Hum Retroviruses · November 1993
HIV-1 infection evokes a vigorous antiviral response that may participate in resolving the initial peak of plasma viremia and maintenance of the asymptomatic state. CD8+ T lymphocytes of HIV-1-infected individuals play a critical role in the cellular anti- ...
Full textLink to itemCite
Journal ArticleAntimicrob Agents Chemother · November 1993
Yeast strains isolated from the oropharynx of 87 consecutive patients infected with human immunodeficiency virus type 1 were examined for in vitro susceptibility to fluconazole. Candida albicans was isolated from 73 patients. Fifty-one patients had receive ...
Full textLink to itemCite
Journal ArticleJ Am Acad Dermatol · July 1993
The worldwide epidemic of human immunodeficiency virus (HIV) infection will likely be considered the most important public health event of the twentieth century. During the past 15 years, a wealth of information relating to the epidemiology, diagnosis, nat ...
Full textLink to itemCite
Journal ArticleAIDS Research and Human Retroviruses · 1993
HIV-1 infection evokes a vigorous antiviral response that may participate in resolving the initial peak of plasma viremia and maintenance of the asymptomatic state. CD8+ T lymphocytes of HIV-1-infected individuals play a critical role in the cellular anti- ...
Cite
Journal ArticleJ Virol · August 1991
The influence of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of freshly isolated normal human peritoneal macrophages and blood monocytes was examined. Each of 14 HIV antibody-positive human serum samples was found to ...
Full textLink to itemCite
Journal ArticleCell Immunol · August 1991
Human immunodeficiency virus type-1 (HIV-1)-infected individuals exhibit functional impairment in various forms of cell-mediated cytotoxicities (CMC) at all stages of disease. The purpose of this study was to determine (i) if peripheral blood mononuclear c ...
Full textLink to itemCite
Journal ArticleJAMA · March 27, 1991
We randomized 389 symptomatic patients with human immunodeficiency virus (HIV) infection to ditiocarb sodium (400 mg/m2 orally for 24 weeks) or a placebo. Patients were well balanced according to Centers for Disease Control (CDC) group, CD4+ cell number, a ...
Link to itemCite
Journal ArticleRev Infect Dis · 1991
Cryptococcosis is a common opportunistic infection in patients with AIDS. Meningitis is the most frequent manifestation of infection with Cryptococcus neoformans; pneumonia due to this organism, though less frequently recognized, is also a significant enti ...
Full textLink to itemCite
Journal ArticleJournal of the American Medical Association · 1991
Objectives. - To determine if racial-ethnic differences exist in survival, disease progression, and development of myelosuppression in zidovudine- treated patients with advanced human immunodeficiency virus (HIV) disease. Design. - Prospective observationa ...
Full textCite
Journal ArticleOncology (Williston Park) · November 1990
After much frustration in the last decade, HIV therapeutics is an emerging discipline. Over the past few years a number of new agents have been evaluated, including such antiviral drugs as zidovudine, dideoxycytidine and dideoxyinosine, and immunomodulator ...
Link to itemCite
Journal ArticleJ Infect Dis · June 1990
The polymerase chain reaction (PCR) was used to detect human immunodeficiency virus type 1 (HIV-1) proviral sequences (gag and env) in nucleated cells from the cerebrospinal fluid (CSF) of 31 HIV-1-positive patients, and the results were compared with clin ...
Full textLink to itemCite
Journal ArticleJ Immunol · May 1, 1990
HIV-1-specific cell-mediated cytotoxicity (CMC) is a form of antibody-dependent cellular cytotoxicity (ADCC) in which HIV-1-specific antibodies arm NK cells directly to become cytotoxic for targets bearing HIV-1 antigenic determinants. This non-MHC-restric ...
Link to itemCite
Journal ArticleN Engl J Med · April 5, 1990
Zidovudine (AZT) is a potent inhibitor of the replication of the human immunodeficiency virus (HIV), and it has been shown to improve survival in advanced HIV disease. We conducted a randomized, double-blind trial in adults with asymptomatic HIV infection ...
Full textLink to itemCite
Journal ArticleAnn Surg · February 1990
Thrombocytopenic purpura is a common hematologic abnormality occurring in individuals infected with the human immunodeficiency virus, HIV-1. Of the nearly two million people infected with HIV-1, approximately 11% have platelet counts of less than 100,000/m ...
Full textLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr (1988) · 1990
While anemia and a positive direct anti-globulin test are each frequently observed in the clinical syndrome of human immunodeficiency virus (HIV) infection, autoimmune hemolytic anemia has rarely been reported in this setting. A case of severe warm autoimm ...
Link to itemCite
Journal ArticleAntimicrob Agents Chemother · October 1989
The objectives of this open-labeled, multiple-dose, three-way-crossover trial were to evaluate the safety and tolerance of zidovudine (Retrovir) oral syrup and to assess the bioequivalence of this formulation relative to zidovudine solution and capsule for ...
Full textLink to itemCite
Journal ArticleLancet · July 8, 1989
30 patients with recurrent zidovudine-induced neutropenia were followed up for a total of 493 months of treatment to evaluate their risk of bacterial infection. Zidovudine was temporarily discontinued only when the polymorphonuclear (PMN) cell count fell t ...
Full textLink to itemCite
Journal ArticleVirology · April 1989
The sequences of the M1 and M3 genome segments of reovirus serotype 3 strain Dearing, which encode protein mu 2, a minor capsid, component, and protein mu NS, one of the two nonstructural proteins, are reported. They are 2304 and 2235 base pairs long, resp ...
Full textLink to itemCite
Journal ArticleVirology · November 1988
We present the sequence of reovirus serotype 3 (strain Dearing) genome segment L3 which encodes protein lambda 1, one of the two major components of the core shell. The genome segment is 3896 nucleotides long, with 5'- and 3'-noncoding regions of 13 and 18 ...
Full textLink to itemCite
Journal ArticleMedicine (Baltimore) · September 1987
While salmonellosis is often considered to affect primarily the gastrointestinal tract, infection at other sites may occur, producing characteristic clinical syndromes. We reviewed cases from our institutions and the literature on focal manifestations of s ...
Full textLink to itemCite